Vital Signs

Showing 41-50 of 307

This issue of Vital Signs, released on March 5, 2007, provides a strategic overview of the potential impact of microfluidics in the healthcare and life sciences areas. Additionally, an emerging company profile is provided for Cepheid, a molecular diagnostics company that develops and markets fully-integrated genetic analysis systems for the industr...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on March 12, 2007, provides a strategic overview of trends in the use of the Internet by Americans to obtain health information. Additionally, an emerging company profile is provided for Enclarity, Inc., a leader in information management for the healthcare industry. Reimbursement and regulatory news from the FDA...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on March 19, 2007, provides a strategic overview of the potential impact of regulatory changes on the total joint replacement market. Additionally, an emerging company profile is provided for NovaBone Products, a player in the synthetic bone grafting materials industry. Reimbursement and regulatory news from the ...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on March 26, 2007, provides a strategic overview of factors that are expected to be important for consumer-directed healthcare and price transparency efforts. Additionally, an emerging company profile is provided for Revolution Health, a leader in online health management tools. Reimbursement and regulatory news ...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on April 2, 2007, provides a strategic overview of the potential for specialty generics in the pharmaceutical industry. Additionally, an emerging company profile is provided for Abrika Pharmaceuticals, an emerging specialty generic pharmaceuticals company. Reimbursement and regulatory news from the FDA and CMS is...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on April 9, 2007, provides a strategic overview of the impact of consolidation in the life sciences and drug discovery technologies market. Additionally, an emerging company profile is provided for Network Biosystems, a developer of DNA analysis technologies for forensics, clinical diagnostics, homeland security,...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on April 16, 2007, provides a strategic overview challenges and opportunities relative to cervical cancer screening in developing countries. Additionally, an emerging company profile is provided for FORTH-photonics, a developer of biophotonic technologies for non-invasive diagnosis and screening applications. Rei...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on April 23, 2007, provides a strategic overview of leading healthcare IT trends. Additionally, an emerging company profile is provided for DocuTAP, a developer of workflow software solutions that are accessible through mobile devices. Reimbursement and regulatory news from the FDA and CMS is also provided for Ap...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on April 30, 2007, provides a strategic overview of the potential impact of changing reimbursement trends on the cardiac monitoring market. Additionally, an emerging company profile is provided for LifeSync Corporation, a developer of wireless monitoring products. Reimbursement and regulatory news from the FDA an...

USD 1,500.00

USD 1,125.00 save 25 %

This issue of Vital Signs, released on May 7, 2007, provides a strategic overview of dynamics in the computed tomography imaging market. Additionally, an emerging company profile is provided for NeuroLogica Corporation, a neuroscience based medical imaging company. Reimbursement and regulatory news from the FDA is also provided for April 23 - April...

USD 1,500.00

USD 1,125.00 save 25 %

Showing 41-50 of 307